PMID- 29485740 OWN - NLM STAT- MEDLINE DCOM- 20190723 LR - 20231103 IS - 1860-7187 (Electronic) IS - 1860-7179 (Print) IS - 1860-7179 (Linking) VI - 13 IP - 10 DP - 2018 May 23 TI - Discovery of Molidustat (BAY 85-3934): A Small-Molecule Oral HIF-Prolyl Hydroxylase (HIF-PH) Inhibitor for the Treatment of Renal Anemia. PG - 988-1003 LID - 10.1002/cmdc.201700783 [doi] AB - Small-molecule inhibitors of hypoxia-inducible factor prolyl hydroxylases (HIF-PHs) are currently under clinical development as novel treatment options for chronic kidney disease (CKD) associated anemia. Inhibition of HIF-PH mimics hypoxia and leads to increased erythropoietin (EPO) expression and subsequently increased erythropoiesis. Herein we describe the discovery, synthesis, structure-activity relationship (SAR), and proposed binding mode of novel 2,4-diheteroaryl-1,2-dihydro-3H-pyrazol-3-ones as orally bioavailable HIF-PH inhibitors for the treatment of anemia. High-throughput screening of our corporate compound library identified BAY-908 as a promising hit. The lead optimization program then resulted in the identification of molidustat (BAY 85-3934), a novel small-molecule oral HIF-PH inhibitor. Molidustat is currently being investigated in clinical phase III trials as molidustat sodium for the treatment of anemia in patients with CKD. CI - (c) 2018 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA. FAU - Beck, Hartmut AU - Beck H AUID- ORCID: 0000-0002-7826-8467 AD - Medicinal Chemistry Wuppertal, Bayer AG, 42096, Wuppertal, Germany. FAU - Jeske, Mario AU - Jeske M AUID- ORCID: 0000-0002-6680-8948 AD - Medicinal Chemistry Wuppertal, Bayer AG, 42096, Wuppertal, Germany. FAU - Thede, Kai AU - Thede K AD - Medicinal Chemistry Berlin, Bayer AG, 13342, Berlin, Germany. FAU - Stoll, Friederike AU - Stoll F AUID- ORCID: 0000-0002-0681-4799 AD - Medicinal Chemistry Wuppertal, Bayer AG, 42096, Wuppertal, Germany. FAU - Flamme, Ingo AU - Flamme I AUID- ORCID: 0000-0003-0855-7850 AD - Cardiology Research Wuppertal, Bayer AG, 42096, Wuppertal, Germany. FAU - Akbaba, Metin AU - Akbaba M AD - Medicinal Chemistry Wuppertal, Bayer AG, 42096, Wuppertal, Germany. FAU - Erguden, Jens-Kerim AU - Erguden JK AD - Medicinal Chemistry Wuppertal, Bayer AG, 42096, Wuppertal, Germany. FAU - Karig, Gunter AU - Karig G AUID- ORCID: 0000-0002-5005-5283 AD - Medicinal Chemistry Wuppertal, Bayer AG, 42096, Wuppertal, Germany. FAU - Keldenich, Jorg AU - Keldenich J AD - DMPK Wuppertal, Bayer AG, 42096, Wuppertal, Germany. FAU - Oehme, Felix AU - Oehme F AD - Cardiology Research Wuppertal, Bayer AG, 42096, Wuppertal, Germany. FAU - Militzer, Hans-Christian AU - Militzer HC AD - Chemical Development Wuppertal, Bayer AG, 42096, Wuppertal, Germany. FAU - Hartung, Ingo V AU - Hartung IV AUID- ORCID: 0000-0001-8175-7352 AD - Medicinal Chemistry Berlin, Bayer AG, 13342, Berlin, Germany. FAU - Thuss, Uwe AU - Thuss U AUID- ORCID: 0000-0001-8423-2017 AD - DMPK Wuppertal, Bayer AG, 42096, Wuppertal, Germany. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180414 PL - Germany TA - ChemMedChem JT - ChemMedChem JID - 101259013 RN - 0 (Pyrazoles) RN - 0 (Triazoles) RN - 9JH486CZ13 (molidustat) RN - EC 1.14.11.29 (Hypoxia-Inducible Factor-Proline Dioxygenases) MH - Anemia/*drug therapy/etiology MH - Animals MH - Binding Sites MH - Cell Line, Tumor MH - Drug Discovery MH - Humans MH - Hypoxia-Inducible Factor-Proline Dioxygenases/*antagonists & inhibitors MH - Kidney Diseases/*complications MH - Mice MH - Molecular Structure MH - Protein Binding MH - Protein Conformation MH - Pyrazoles/*pharmacology/therapeutic use MH - Structure-Activity Relationship MH - Triazoles/*pharmacology/therapeutic use PMC - PMC6001664 OTO - NOTNLM OT - BAY 85-3934 OT - HIF-PH OT - inhibitors OT - metalloenzymes OT - molidustat EDAT- 2018/02/28 06:00 MHDA- 2019/07/25 06:00 PMCR- 2018/06/14 CRDT- 2018/02/28 06:00 PHST- 2017/12/14 00:00 [received] PHST- 2018/02/20 00:00 [revised] PHST- 2018/02/28 06:00 [pubmed] PHST- 2019/07/25 06:00 [medline] PHST- 2018/02/28 06:00 [entrez] PHST- 2018/06/14 00:00 [pmc-release] AID - CMDC201700783 [pii] AID - 10.1002/cmdc.201700783 [doi] PST - ppublish SO - ChemMedChem. 2018 May 23;13(10):988-1003. doi: 10.1002/cmdc.201700783. Epub 2018 Apr 14.